1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Key Product USP Analysis
4.2. Regulatory Scenario
4.3. Reimbursement Scenario
4.4. Value Chain
4.5. Disease Epidemiology by Region
5. Global Lung Cancer Surgery Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018and Forecast, 2019-2029
5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Market Background
6.1. Macro-Economic Factors
6.1.1. Global GDP Growth Outlook
6.1.2. Global Healthcare Market Outlook
6.2. Forecast Factors – Relevance & Impact
6.3. Market Dynamics
6.3.1. Drivers
6.3.2. Restraints
6.3.3. Opportunity Analysis
7. Global Lung Cancer Surgery Market Analysis 2014-2018 and Forecast 2019-2029, by Product Type
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2014 – 2018
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2019 – 2029
7.3.1. Thoracoscopes
7.3.2. Mediastinoscopes
7.3.3. Bronchoscopes
7.3.4. Robotic-Assisted Thoracic Surgery Systems
7.3.5. Surgical Staplers
7.3.6. Surgical Energy Instruments
7.3.6.1. Advanced Energy Instruments
7.3.6.1.1. Advanced Bipolar Instruments
7.3.6.1.2. Ultrasonic Instruments
7.3.6.2. Basic Energy Instruments
7.3.6.2.1. Bipolar Instruments
7.3.6.2.2. Monopolar Instruments
7.4. Market Attractiveness Analysis By Product Type
8. Global Lung Cancer Surgery Market Analysis 2014-2018 and Forecast 2019-2029, by Application
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Application, 2014 – 2018
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2019 – 2029
8.3.1. Lobectomy
8.3.2. Segmentectomy
8.3.3. Wedge Resection
8.3.4. Pneumonectomy
8.4. Market Attractiveness Analysis By Application
9. Global Lung Cancer Surgery Market Analysis 2014-2018 and Forecast 2019-2029, by End User
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By End User, 2014 – 2018
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2019 – 2029
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.4. Market Attractiveness Analysis By End User
10. Lung Cancer Surgery Market Analysis 2014-2018 and Forecast 2019-2029, By Region
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By End User, 2014 – 2018
10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 – 2029
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. Middle East and Africa (MEA)
10.3.5. East Asia
10.3.6. South Asia
10.3.7. Oceania
10.4. Market Attractiveness Analysis By Region
11. North America Lung Cancer Surgery Market Analysis 2014-2018 and Forecast 2019-2029
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018
11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029
11.3.1. By Country
11.3.1.1. U.S.
11.3.1.2. Canada
11.3.2. By Product Type
11.3.3. By Application
11.3.4. By End User
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Product Type
11.4.3. By Application
11.4.4. By End User
12. Latin America Lung Cancer Surgery Market Analysis 2014-2018 and Forecast 2019-2029
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Mexico
12.3.1.3. Rest of Latin America
12.3.2. By Product Type
12.3.3. By Application
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Product Type
12.4.3. By Application
12.4.4. By End User
13. Europe Lung Cancer Surgery Market Analysis 2014-2018 and Forecast 2019-2029
13.1. Introduction
13.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 – 2018
13.3. Market Size (US$ Mn) and By Market Taxonomy, 2019 – 2029
13.3.1. By Country
13.3.1.1. Germany
13.3.1.2. Italy
13.3.1.3. France
13.3.1.4. U.K.
13.3.1.5. Spain
13.3.1.6. Russia
13.3.1.7. Rest of Europe
13.3.2. By Product Type
13.3.3. By Application
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product Type
13.4.3. By Application
13.4.4. By End User
14. South Asia Lung Cancer Surgery Market Analysis 2014-2018 and Forecast 2019-2029
14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 – 2018
14.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 – 2029
14.3.1. By Country
14.3.1.1. India
14.3.1.2. Thailand
14.3.1.3. Indonesia
14.3.1.4. Malaysia
14.3.1.5. Rest of South Asia
14.3.2. By Product Type
14.3.3. By Application
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product Type
14.4.3. By Application
14.4.4. By End User
15. East Asia Lung Cancer Surgery Market Analysis 2014-2018 and Forecast 2019-2029
15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 – 2018
15.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 – 2029
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Product Type
15.3.3. By Application
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product Type
15.4.3. By Application
15.4.4. By End User
16. Oceania Lung Cancer Surgery Market Analysis 2014-2018 and Forecast 2019-2029
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 – 2018
16.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 – 2029
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Product Type
16.3.3. By Application
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product Type
16.4.3. By Application
16.4.4. By End User
17. Middle East and Africa Lung Cancer Surgery Market Analysis 2014-2018 and Forecast 2019-2029
17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 – 2018
17.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 – 2029
17.3.1. By Country
17.3.1.1. GCC Countries
17.3.1.2. Turkey
17.3.1.3. Northern Africa
17.3.1.4. South Africa
17.3.1.5. Rest of Middle East and Africa
17.3.2. By Product Type
17.3.3. By Application
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product Type
17.4.3. By Application
17.4.4. By End User
18. Emerging Countries Lung Cancer Surgery Market Analysis 2014-2018 and Forecast 2019-2029
18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. China Lung Cancer Surgery Market Analysis
18.2.1. Introduction
18.2.2. Market Value Proportion Analysis by Market Taxonomy
18.2.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
18.2.3.1. By Product Type
18.2.3.2. By Application
18.2.3.3. By End User
18.2.4. China Lung Cancer Surgery Market – Competition Landscape
18.3. India Lung Cancer Surgery Market Analysis
18.3.1. Introduction
18.3.2. Market Value Proportion Analysis by Market Taxonomy
18.3.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
18.3.3.1. By Product Type
18.3.3.2. By Application
18.3.3.3. By End User
18.3.4. India Lung Cancer Surgery Market – Competition Landscape
18.4. Brazil Lung Cancer Surgery Market Analysis
18.4.1. Introduction
18.4.2. Market Value Proportion Analysis by Market Taxonomy
18.4.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
18.4.3.1. By Product Type
18.4.3.2. By Application
18.4.3.3. By End User
18.4.4. Brazil Lung Cancer Surgery Market – Competition Landscape
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Concentration
19.3. Market Share Analysis of Top Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Deep Dive
20.2.1. Asap Endoscopic Products
20.2.1.1. Overview
20.2.1.2. Product Portfolio
20.2.1.3. Profitability by Market Segments (Product/Channel/Region)
20.2.1.4. Sales Footprint
20.2.1.5. Strategy Overview
20.2.2. Ethicon Inc. (J & J)
20.2.2.1. Overview
20.2.2.2. Product Portfolio
20.2.2.3. Profitability by Market Segments (Product/Channel/Region)
20.2.2.4. Sales Footprint
20.2.2.5. Strategy Overview
20.2.3. Medtronic Plc.
20.2.3.1. Overview
20.2.3.2. Product Portfolio
20.2.3.3. Profitability by Market Segments (Product/Channel/Region)
20.2.3.4. Sales Footprint
20.2.3.5. Strategy Overview
20.2.4. Germed USA Inc.
20.2.4.1. Overview
20.2.4.2. Product Portfolio
20.2.4.3. Profitability by Market Segments (Product/Channel/Region)
20.2.4.4. Sales Footprint
20.2.4.5. Strategy Overview
20.2.5. Teleflex Incorporated
20.2.5.1. Overview
20.2.5.2. Product Portfolio
20.2.5.3. Profitability by Market Segments (Product/Channel/Region)
20.2.5.4. Sales Footprint
20.2.5.5. Strategy Overview
20.2.6. B. Braun Melsungen AG
20.2.6.1. Overview
20.2.6.2. Product Portfolio
20.2.6.3. Profitability by Market Segments (Product/Channel/Region)
20.2.6.4. Sales Footprint
20.2.6.5. Strategy Overview
20.2.7. Karl Storz
20.2.7.1. Overview
20.2.7.2. Product Portfolio
20.2.7.3. Profitability by Market Segments (Product/Channel/Region)
20.2.7.4. Sales Footprint
20.2.7.5. Strategy Overview
20.2.8. Richard Wolf
20.2.8.1. Overview
20.2.8.2. Product Portfolio
20.2.8.3. Profitability by Market Segments (Product/Channel/Region)
20.2.8.4. Sales Footprint
20.2.8.5. Strategy Overview
20.2.9. Olympus Medical Systems Corp
20.2.9.1. Overview
20.2.9.2. Product Portfolio
20.2.9.3. Profitability by Market Segments (Product/Channel/Region)
20.2.9.4. Sales Footprint
20.2.9.5. Strategy Overview
20.2.10. Intuitive Surgical Inc.
20.2.10.1. Overview
20.2.10.2. Product Portfolio
20.2.10.3. Profitability by Market Segments (Product/Channel/Region)
20.2.10.4. Sales Footprint
20.2.10.5. Strategy Overview
20.2.11. Ambu A/S
20.2.11.1. Overview
20.2.11.2. Product Portfolio
20.2.11.3. Profitability by Market Segments (Product/Channel/Region)
20.2.11.4. Sales Footprint
20.2.11.5. Strategy Overview
20.2.12. PENTAX Medical Company
20.2.12.1. Overview
20.2.12.2. Product Portfolio
20.2.12.3. Profitability by Market Segments (Product/Channel/Region)
20.2.12.4. Sales Footprint
20.2.12.5. Strategy Overview
20.2.13. FUJIFILM Holdings Corporation
20.2.13.1. Overview
20.2.13.2. Product Portfolio
20.2.13.3. Profitability by Market Segments (Product/Channel/Region)
20.2.13.4. Sales Footprint
20.2.13.5. Strategy Overview
21. Assumptions and Acronyms Used
22. Research Methodology
【免責事項】
http://www.globalresearch.jp/disclaimer